Company / Operating Income
AbbVie Operating Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
$15.1B
FY2025
5-year range
$9.1B / $18.1B
FY2021-FY2025
Trend
+65.0%
vs FY2024
Sector context
#1 of 202
Health Care
What the data says
Among 202 Health Care companies, AbbVie is in the top 0% for operating income. Operating Income returned to growth in FY2025 after 2 years of decline, reaching $15.1B.
Based on SEC 10-K filings.
$15.1B in FY2025 with a 5-year CAGR of +5.8%. Ranks 1st among 202 companies in Health Care.
Improved from $12.8B to $15.1B over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -5.9%
- 5-Year CAGR
- +5.8%
- 10-Year CAGR
- -
Sector benchmark
Top 0% in Health CareTop 0% of 202This company $15.1B Sector average $86.7M
▼
+17292.7% above sector average
Key checks
Key Insights
- 5-year CAGR of +5.8%, indicating consistent growth.
- In FY2025, operating income increased 65.0% year-over-year.
- Ranks #1 out of 202 companies in the Health Care sector.
- Peak operating income was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.62 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $15.1B | +65.0% |
| FY2024 | $9.1B | -28.4% |
| FY2023 | $12.8B | -29.6% |
| FY2022 | $18.1B | +1.1% |
| FY2021 | $17.9B | +57.7% |
| FY2020 | $11.4B | -12.5% |
| FY2019 | $13.0B | +103.4% |
| FY2018 | $6.4B | -33.1% |
| FY2017 | $9.5B | +2.2% |
| FY2016 | $9.3B | +23.9% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026